| Date | Title | Description |
| 08.10.2024 | CHF 10 million to advance Somagenetix' first gene therapy candidate into a clinical trial |
Founded in 2019, as a spin-off of the University of Zurich (UZH), Somagenetix AG is at the forefront of gene therapy innovation, focused on curing phagocyte disorders with a one-time treatment. The company has built a best-in-class gene th... |
| 18.09.2024 | Vi Partners leads CHF 3m round for Almer Technologies |
Almer Technologies is a Bern-based startup dedicated to creating an augmented reality (AR) headset tailored for industrial applications. Its flagship product, Almer Arc, 2 provides a lightweight, user-friendly, and cost-effective alternati... |
| 22.08.2024 | FLOWIT sichert sich 4 Millionen Franken in überzeichneter Seed-Runde |
Mit der Lösung von FLOWIT haben alle Mitarbeitende – insbesondere auch diejenigen an der Front, wie Servicetechniker, Pflegekräfte, Gastronomie- und andere Non-Desktop-Mitarbeitende –, Zugang zu Echtzeit-Feedback und -Entwicklung. Diese Zi... |
| 25.06.2024 | iOnctura's Precision Cancer Treatments Gain Momentum | iOnctura, a clinical-stage biopharmaceutical company based in Amsterdam, recently secured EUR80 million in Series B financing to accelerate the development of their lead asset, roginolisib, for the treatment of uveal melanoma and other onco... |
| 24.06.2024 | iOnctura closes EUR80 million Series B financing |
iOnctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces that it has closed an EUR80 million Series B financing. The funding round was led by new investor Syncona Limited with part... |
| 29.12.2023 | LeaseTeq raises CHF8 million to digitize leasing | |
| 19.12.2023 | GenAI fintech Unique raises additional CHF 5.6 million | |
| 15.08.2023 | Dutch medtech firm Xeltis secures €12.5M from EIC Fund | Dutch medtech firm Xeltis has secured €12.5 million in funding from the European Innovation Council (EIC) Fund. This brings Xeltis' total amount raised, to date, to €44.5 million. Its investors include DaVita Venture Group, EQT Life Science... |
| 03.03.2023 | Oculis goes public on Nasdaq | |
| 24.01.2023 | Acodis secures CHF 6 million | |
| 25.10.2022 | Vara Raises $4.4 Million In Funding To Bring Its Groundbreaking AI Breast Cancer Screening Platform To Millions More Women | For women, their gender is the strongest breast cancer risk factor, as approximately less than 1% of ... [+] breast cancers occur in mengetty |
| 18.10.2022 | Oculis to go public via SPAC | |
| 21.09.2022 | Ledgy banks $22 million in Series B round | |
| 13.07.2022 | USD 1 million for smart productivity calendar | |
| 27.04.2022 | VI Partners leads Picterra’s $6.5M investment round | |
| 11.04.2022 | Unique raises USD $6.4 million seed extension and acquires Ciara | |
| 01.04.2022 | Additional $14 million for Altoida to advance its neurocognitive assessment platform | |
| 24.02.2022 | Growth funding round for Equippo | |
| 07.09.2021 | Ledgy completes $10 million series A round | Alongside Sequoia Capital further participants in the round are Xavier Niel, Harry Stebbings, Visionaries Club, and several leading SaaS founders including UiPath's Daniel Dines and Front's Mathilde Collin. Existing investors Myke Näf, Paul... |
| 07.05.2021 | Oculis closes US$57 million Series C financing | The oversubscribed round was co-led by new investors BVCF Management and Hyfinity Investments, with VI Partners and Wille AG joining the company’s existing investors, Bay City Capital, Brunnur Ventures, EarlyBird, funds managed by Tekla Cap... |
| 07.05.2021 | Oculis closes US$57 million Series C financing | |
| 14.04.2021 | Medical device company CeQur raises $115 million | The round is the largest fundraising to date for a privately held medtech company in Europe. Credit Suisse Entrepreneur Capital Ltd. and Endeavour Vision led the financing with significant participation from new investors, including Tandem ... |
| 14.04.2021 | Medical device company CeQur raises $115 million | |
| 22.10.2020 | A CHF 15.2 Million seed investment brings Araris Biotech a step further | There are nine antibody-drug conjugates (ADC) approved by the FDA; however, many of them cannot be dosed high enough to elicit efficacy. This is due to systemic toxicity often caused by linker instability or heterogeneous distributions of t... |
| 22.10.2020 | A CHF 15.2 Million seed investment brings Araris Biotech a step further | |
| 09.10.2020 | Medlumics raises €14M in a Series E financing co-led by Asabys Partners, VI Partners and CDTI Innvierte, together with existing investors Andera Partners, Caixa Capital Risc and Innogest | Medlumics, which develops Ablaview®, a unique RF irrigated ablation catheter system that merges photonics and miniaturized optics to guide device placement and directly assess the ablation lesions in real time, announces today the closing o... |
| 08.10.2020 | Medlumics cierra una ronda de €14M co-liderada por Asabys Partners, VI Partners y CDTI Innvierte, junto con los inversores actuales Andera Partners, CaixaCR e Innogest Capital | 08/10/2020
Nota de prensa
MEDLUMICS CIERRA UNA RONDA DE €14M CO-LIDERADA POR ASABYS PARTNERS, VI PARTNERS Y CDTI INNVIERTE, JUNTO CON LOS INVERSORES ACTUALES ANDERA PARTNERS, CAIXACR E INNOGEST CAPITAL.
• Medlumics desarrolla un catéter ... |
| 14.07.2020 | iOnctura extends series A round to €20 million | |
| 14.07.2020 | iOnctura extends series A round to €20 million | iOnctura SA is a clinical-stage biopharmaceutical company developing a pipeline of next-generation molecules targeting cancer and fibrosis. The company’s lead programme, IOA-244, entered the clinic in Q1 2020 to clinically demonstrate for t... |
| 18.05.2020 | VI Partners hits €71m first close for medtech, deeptech investment fund | Swiss investment house VI Partners has hit a €71m first close for a new fund targeting medical and deep-tech investmen |
| 13.05.2020 | VI Partners launches a new early-stage venture fund for Switzerland | |
| 13.05.2020 | VI Partners launches a new early-stage venture fund for Switzerland | A new fund advised by VI Partners made a first closing in April 2020 with CHF 75m (EUR 71m). It has been supported by its anchor investors Venture Incubator, an evergreen investment structure with corporate investors (ABB, Bühler, Crédit Su... |
| 24.01.2020 | Geneva-based biopharma startup raises €15 million | iOnctura is a clinical-stage biopharmaceutical company founded as a spin-out from Merck, with Merck and Cancer Research UK. The company provides a best-in-class pipeline of molecules that harness both direct and immune-mediated anti-cancer ... |
| 24.01.2020 | Geneva-based biopharma startup raises €15 million | |
| 04.11.2019 | Wingman Ventures announces first closing of seed fund | |
| 06.09.2019 | Xeltis’ closes €10.5 million Series D financing | |
| 20.08.2019 | Araris obtains CHF 2.5 million after only six months of existence | |
| 03.07.2019 | L.E.S.S. raises CHF 14 million to enter the automotive market | |
| 31.05.2019 | Digital Health Startup Altoida Raises $6.3M Series A | |
| 12.12.2018 | Nexthink Raises $85M to Help Companies Improve the Digital Employee Experience | Nexthink®, the leader in digital employee experience management software for enterprises, today announced it has secured an $85 million funding round. The financing was led by Index Ventures and includes participation from returning investo... |
| 12.12.2018 | Nexthink Raises $85 Million | |
| 03.12.2018 | Eine Million Euro für Ledgy | |
| 12.11.2018 | AMAL Therapeutics finalises CHF 33 million Series B round | |
| 15.11.2017 | Xeltis mit Rekordfinanzierung | |
| 15.11.2017 | Xeltis Closes €45 Million in Series C Financing | |
| 05.09.2017 | AMAL Therapeutics Raises €8 Million (CHF 8.8 Million) in First Closing of Series B Financing Round | Financing round co-led by Boehringer Ingelheim Venture Fund, BioMedPartners and Helsinn Investment Fund |
| 10.01.2017 | 13.5 Millionen Franken für Advanon | |
| 23.06.2016 | MassChallenge sets up camp in Switzerland | Bérénice Magistretti Contributor
Bérénice Magistretti is a Swiss freelance writer based in San Francisco. She focuses on startups in Saudi Arabia, Switzerland and emerging markets.
More posts by this contributor
Swiss data analytics company... |
| 26.05.2016 | Fundings-in-Brief: Antimicrobial Startup Raises $1.3m, Food E-Commerce Raises $131m, Farmers Edge Raises $3m, more | PURE Bioscience Raises $1.27m for Antimicrobial Tech in Warrant Exercise
Antimicrobial tech developer PURE Bioscience has raised $1.27 million from the recent exercise of 2.8 million warrants that expired May 23, 2016. The funding will be u... |
| 23.05.2016 | Gamaya closes CHF 3.2 Million Series A financing round | |
| 22.01.2016 | Winning start for DigitalZurich 2025 | |
| 15.12.2015 | Weiterer Investor für Internet-Marktplatz Equippo | |
| 28.04.2015 | L .E.S.S. SA closes CHF 3 .0 million Series A financing | |
| 02.12.2014 | Xeltis closes CHF 32 million Series B financing | |
| 28.04.2014 | Sequana Medical Raises CHF23M in Series C Financing | Sequana Medical AG, a Zurich, Switzerland-based medical device company with innovative fluid management technologies, has raised CHF23m ($26.2m) in a Series C financing.
The round was led by LSP (Life Science Partners), and co-led by NeoMed... |
| 06.11.2013 | Delenex Therapeutics closes CHF 7.3 Million Series A3 Financing | |
| 05.08.2013 | Merz Pharma takes over Swiss dermatology specialist Neocutis | |
| 02.08.2013 | Edimer Secures $18M Series B Financing Led by New Enterprise Associates | |
| 22.06.2012 | Thomas Knecht ist Jungunternehmerförderer des Jahres 2012 | |
| 31.05.2012 | Spinelab Raises CHF4.7M in Series C Financing | Spinelab, a Winterthur, Switzerland-based developer of motion preserving stabilization systems for the spine, has raised CHF4.7m (approximately $4.9m) in Series C financing.
The round, which brought the total amount raised by the company to... |
| 31.05.2012 | Spinelab raises CHF 4.7 million in Series C financing round | |
| 24.02.2012 | Bilanz widmet Schweizer Internet-Szene Titelstory | |
| - | Swiss equity management platform Ledgy raises $10 million in Sequoia led round | Built with high-growth companies in mind, Zürich-based equity management platform Ledgy has raised $10 million in a Series A funding round. The startup automates a number of equity-related business processes, provides various financing roun... |
| - | AMAL Therapeutics finalises €29 million (CHF 33.2 million) Series B round | |
